Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
127828-22-2
139115-91-6
165963-71-3
108466-89-3
462100-06-7
1076199-21-7
487-54-7 | 2-Hydroxyhippuric acid | AA00I8Q7 | MFCD00002695
501435-91-2 | 5-Bromo-2-fluoropyridine-3-boronic acid | AA00I8VV | MFCD04039317
511552-46-8 | Butanoic acid, 4-[[(cyclohexylamino)carbonyl]amino]- | AA00I92W | MFCD08442345
51934-37-3 | 5-Methoxynaphthalene-1-carboxylic acid | AA00I97S | MFCD15527522
528872-23-3 | Ethyl 4-bromo-2-nitrobenzoate | AA00I9DB | MFCD12031868
536-57-2 | p-Toluenesulfinic acid | AA00I9HI | MFCD27923420
54293-10-6 | 3-[(methylsulfanyl)methyl]benzoic acid | AA00I9MG | MFCD06655776
5521-55-1 | 5-Methylpyrazine-2-carboxylic acid | AA00I9RP | MFCD29059789
55881-96-4 | 1-(2-Hydroxyethyl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol | AA00I9WG | MFCD01017470
56674-68-1 | 2-(Cyclohexyloxy)propanoic acid | AA00IA15 | MFCD12145311